SOMETHING ELSE FOR THE BDS CROWD TO B, D AND S

Boycott:  a punitive ban that forbids relations with certain groups, cooperation with a policy, or the handling of goods.

Divest:  rid oneself of something that one no longer wants or requires, such as a business interest or investment.

Sanction: a threatened penalty for disobeying a law or rule.

BDS.  Boycott, Divest, Sanction.  That’s pretty complete.  And it’s something of a hallmark for the Israel haters (who don’t have to be Jew haters as well, but I think we know the vast majority are both).

I thought I’d put up something new for them to B, D and S.

From Maayan Jaffe-Hoffman’s article in the Jerusalem Post:

A small team of Israeli scientists think they might have found the first complete cure for cancer.

“We believe we will offer in a year’s time a complete cure for cancer,” said Dan Aridor, of a new treatment being developed by his company, Accelerated Evolution Biotechnologies Ltd. (AEBi), which was founded in 2000 in the ITEK incubator in the Weizmann Science Park. AEBi developed the SoAP platform, which provides functional leads to very difficult targets.

“Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects at a much lower cost than most other treatments on the market,” Aridor said. “Our solution will be both generic and personal.”

Aridor, chairman of the board of AEBi and CEO Dr. Ilan Morad, say their treatment, which they call MuTaTo (multi-target toxin) is essentially on the scale of a cancer antibiotic – a disruption technology of the highest order.

“The probability of having multiple mutations that would modify all targeted receptors simultaneously decreases dramatically with the number of targets used,” Morad continued. “Instead of attacking receptors one at a time, we attack receptors three at a time – not even cancer can mutate three receptors at the same time.”

Is this going to be a game-changer for cancer treatment?  An actual cure?  I guess we’ll know in a year.

On the other hand, if BDS is successful enough, who – other than Israelis – will get to use it?  And if the BDS movement had been successful enough between the company’s start-up in 2000 and now, this would be academic, since AEBi’s research and development would not have gotten to this point in the first place.

Remember, BDSers:  if someone you care about has cancer that might be cured by the company’s multi-target toxin discovery, make sure to tell them they can never use it.  Just add it to the pile of other medical, scientific and technical advances from Israel that they can’t use.  Got to keep that BDS going, right?

And

And, as always, I remind you not to tell them by cell phone.  Most of that technology was developed in Israel too.

Leave a Reply

Your email address will not be published. Required fields are marked *